**Core Concept**
The question is testing the student's knowledge of second-generation antipsychotics, which are a class of medications used to treat schizophrenia and other psychiatric disorders. These medications are also known as serotonin-dopamine antagonists (SDAs) or atypical antipsychotics, as they have a different pharmacological profile compared to first-generation antipsychotics.

**Why the Correct Answer is Right**
Second-generation antipsychotics like **clozapine** work by antagonizing both serotonin (5-HT2) and dopamine (D2) receptors in the brain. This dual-action mechanism is thought to contribute to their efficacy in treating schizophrenia and reducing the risk of extrapyramidal side effects, which are common with first-generation antipsychotics. Clozapine is a potent antagonist of the 5-HT2 receptor, which is involved in the regulation of mood and cognition.

**Why Each Wrong Option is Incorrect**
**Option A:** Haloperidol is a first-generation antipsychotic, which means it primarily blocks dopamine receptors and is associated with a higher risk of extrapyramidal side effects.
**Option B:** Risperidone is another second-generation antipsychotic, but it is not the correct answer as the question asks for a specific medication. Risperidone is a potent antagonist of the 5-HT2 receptor, but its pharmacological profile is different from clozapine.
**Option D:** Olanzapine is a second-generation antipsychotic, but it is not the correct answer. Olanzapine has a similar pharmacological profile to clozapine, but it is not the specific medication being tested.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that second-generation antipsychotics like clozapine have a higher risk of metabolic side effects, such as weight gain and diabetes, due to their potent effects on serotonin and dopamine receptors. This is an important consideration when selecting an antipsychotic medication for a patient.

**Correct Answer:** C. Clozapine